“The Ozempic Era Should Change How We Think About Self-Control”:
Someone who is overweight may have just as much willpower as a thinner person but need to deploy this willpower against stronger desires for food. In effect, thinner individuals might be getting credit for winning a battle that they never had to fight.
We can get clearer about the effects of GLP-1 drugs on self-control by drawing on a distinction between two different ways of acting moderately, which traces back to Aristotle. The first kind of moderate action lines up with how most people think of self-control: effortfully resisting doing something that you believe you shouldn’t do. The ancient Greek word for this form of moderation is enkrateia, which is usually translated into English as ‘continence’ (despite its contemporary associations with bladder control).
As we’ve seen, Ozempic does not seem to make those who take it more continent; it doesn’t help them resist strong temptations to eat more than they think they should. Rather, taking GLP-1 drugs brings people closer to the other form of moderation: sophrosyne, which is usually translated as ‘temperance’. While the continent person experiences many tempting desires and successfully resists them, the temperate person doesn’t face temptations in the first place.
[B]eing a highly self-controlled person seems mainly to involve using proactive strategies to avoid and manage temptations, rather than being good at directly and effortfully resisting them through sheer willpower.
Frankly, I still don’t feel totally comfortable with the idea of Ozempic for both the lack of evidence of its long-term side effects and, more importantly, the feeling that it risks eroding agency. Is the anesthesia of the appetite true “temperance,” or just a mimicry of the virtue?